Clowse, M. E. B., Förger, F., Hwang, C., Thorp, J., Dolhain, R. J. E. M., Tubergen, A. V., … Hale, T. W. (2017). FRI0179 Minimal to no transfer of certolizumab pegol into breast milk: results from cradle, a prospective, postmarketing, multicenter, pharmacokinetic study. In Poster Presentations. BMJ Publishing Group Ltd and European League Against Rheumatism. https://doi.org/10.1136/annrheumdis-2017-eular.2467

Clowse, M. E. B., F. Förger, C. Hwang, J. Thorp, R. J. E. M. Dolhain, A van Tubergen, L. Shaughnessy, et al. “FRI0179 Minimal to no transfer of certolizumab pegol into breast milk: results from cradle, a prospective, postmarketing, multicenter, pharmacokinetic study.” In Poster Presentations. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. https://doi.org/10.1136/annrheumdis-2017-eular.2467.

Clowse MEB, Förger F, Hwang C, Thorp J, Dolhain RJEM, Tubergen AV, et al. FRI0179 Minimal to no transfer of certolizumab pegol into breast milk: results from cradle, a prospective, postmarketing, multicenter, pharmacokinetic study. In: Poster Presentations. BMJ Publishing Group Ltd and European League Against Rheumatism; 2017.

Clowse, M. E. B., et al. “FRI0179 Minimal to no transfer of certolizumab pegol into breast milk: results from cradle, a prospective, postmarketing, multicenter, pharmacokinetic study.” Poster Presentations, BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. Crossref, doi:10.1136/annrheumdis-2017-eular.2467.

Clowse MEB, Förger F, Hwang C, Thorp J, Dolhain RJEM, Tubergen AV, Shaughnessy L, Simpson J, Teil M, Toublanc N, Wang M, Hale TW. FRI0179 Minimal to no transfer of certolizumab pegol into breast milk: results from cradle, a prospective, postmarketing, multicenter, pharmacokinetic study. Poster Presentations. BMJ Publishing Group Ltd and European League Against Rheumatism; 2017.